Mitomycin is do out next month, and after talking with several oncologists in the Dallas area, they believe that it will offer advantages over traditional intravenous chemotherapy as mitomycin is an intramuscular drug. Shots versus IV therapy that eats up veins.
Remember the market's been bearish the last few days and almost everything has taken a hit. Hold on to this one, and I believe that you will be rewarded. Just the medical perspective. Long on SUPG
This is a dud of a stock! Every time there is good news about this company it goes down further. What the blazes is wrong with this company? Why have they not been on the marketing blitz with mitomycin??? No news about it in Wall ST. Why does the co. remain silent??? I lost a fair amount on this Sh.... stock!!